BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7554081)

  • 1. P53 polymorphisms and haplotypes in lung cancer.
    Birgander R; Själander A; Rannug A; Alexandrie AK; Sundberg MI; Seidegård J; Tornling G; Beckman G; Beckman L
    Carcinogenesis; 1995 Sep; 16(9):2233-6. PubMed ID: 7554081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 germ line haplotypes associated with increased risk for colorectal cancer.
    Själander A; Birgander R; Athlin L; Stenling R; Rutegård J; Beckman L; Beckman G
    Carcinogenesis; 1995 Jul; 16(7):1461-4. PubMed ID: 7614678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 polymorphisms and haplotypes in nasopharyngeal cancer.
    Birgander R; Själander A; Zhou Z; Fan C; Beckman L; Beckman G
    Hum Hered; 1996; 46(1):49-54. PubMed ID: 8825463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 polymorphisms and haplotypes in breast cancer.
    Själander A; Birgander R; Hallmans G; Cajander S; Lenner P; Athlin L; Beckman G; Beckman L
    Carcinogenesis; 1996 Jun; 17(6):1313-6. PubMed ID: 8681448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 polymorphisms and haplotypes show distinct differences between major ethnic groups.
    Själander A; Birgander R; Saha N; Beckman L; Beckman G
    Hum Hered; 1996; 46(1):41-8. PubMed ID: 8825462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 mutations, polymorphisms, and haplotypes in Pakistani ethnic groups and breast cancer patients.
    Khaliq S; Hameed A; Khaliq T; Ayub Q; Qamar R; Mohyuddin A; Mazhar K; Qasim-Mehdi S
    Genet Test; 2000; 4(1):23-9. PubMed ID: 10794357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the p21 codon 31 A1 (arg) allele and lung cancer.
    Själander A; Birgander R; Rannug A; Alexandrie AK; Tornling G; Beckman G
    Hum Hered; 1996; 46(4):221-5. PubMed ID: 8807325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
    Wang YC; Chen CY; Chen SK; Chang YY; Lin P
    Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of p53 alleles on placental weight.
    Birgander R; Själander A; Beckman G; Beckman L
    Hum Hered; 1996; 46(5):290-7. PubMed ID: 8854144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of specific genotype and haplotype of p53 gene with cervical cancer in India.
    Mitra S; Misra C; Singh RK; Panda CK; Roychoudhury S
    J Clin Pathol; 2005 Jan; 58(1):26-31. PubMed ID: 15623478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
    To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 polymorphisms and haplotypes in different ethnic groups.
    Själander A; Birgander R; Kivelä A; Beckman G
    Hum Hered; 1995; 45(3):144-9. PubMed ID: 7615299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 haplotype determination in breast cancer.
    Weston A; Pan CF; Ksieski HB; Wallenstein S; Berkowitz GS; Tartter PI; Bleiweiss IJ; Brower ST; Senie RT; Wolff MS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):105-12. PubMed ID: 9037561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.
    Wu X; Zhao H; Amos CI; Shete S; Makan N; Hong WK; Kadlubar FF; Spitz MR
    J Natl Cancer Inst; 2002 May; 94(9):681-90. PubMed ID: 11983757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese.
    Yoshikawa M; Hiyama K; Ishioka S; Maeda H; Maeda A; Yamakido M
    Int J Mol Med; 2000 Jan; 5(1):49-53. PubMed ID: 10601573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of p53 codon 72 polymorphism in Indian primary open angle glaucoma patients.
    Acharya M; Mitra S; Mukhopadhyay A; Khan M; Roychoudhury S; Ray K
    Mol Vis; 2002 Sep; 8():367-71. PubMed ID: 12368717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.
    Sugimura H; Caporaso NE; Shaw GL; Modali RV; Gonzalez FJ; Hoover RN; Resau JH; Trump BF; Weston A; Harris CC
    Carcinogenesis; 1990 Sep; 11(9):1527-30. PubMed ID: 1976046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of p53 gene in Jordanian population and possible associations with breast cancer and lung adenocarcinoma.
    Mahasneh AA; Abdel-Hafiz SS
    Saudi Med J; 2004 Nov; 25(11):1568-73. PubMed ID: 15573180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 germline polymorphisms are associated with an increased risk for breast cancer in German women.
    Wang-Gohrke S; Rebbeck TR; Besenfelder W; Kreienberg R; Runnebaum IB
    Anticancer Res; 1998; 18(3B):2095-9. PubMed ID: 9677474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.